Abstract:Background: Non-coding RNAs (ncRNAs), like long ncRNAs (lncRNAs) and microRNAs (miRNAs), are confirmed to play important roles in the tumorigenesis and deterioration of non-small cell lung cancer (NSCLC). However, the underlying expression profiling and prospective signal pathways of miRNAs associated with lncRNA HOXA11 antisense RNA (HOXA11-AS) in NSCLC remain unknown. Methods: HOXA11-AS was knocked down in A549 cell line and a microarray assay was used to detect the changes of the miRNA profiles. Four miRNA target prediction algorithms were applied to predict the potential target genes of the differentially expressed miRNAs. Bioinformatics analysis including Gene Ontology (GO), Kyoto Encyclopedia of Genes and Genomes (KEGG), protein-protein interactions (PPIs) and network analysis, were performed to investigate the potential functions, pathways and networks of the target genes. The different expression of HOXA11-AS between normal lung and NSCLC tissues was further verified by the data in The Cancer Genome Atlas (TCGA). Additionally, the relationship between the expression of HOXA11-AS and clinical diagnostic value was analyzed by receiver operating characteristic (ROC) curve. Results: Among all the miRNAs from the microarray, 43 and 18 miRNAs were upregulated and downregulated in NSCLC, respectively. According to the degree of the fold change, p value and false discovery rate (FDR), the top five upregulated and downregulated miRNAs were selected for further investigation. GO analysis on the target genes revealed that these de-regulated miRNAs were involved in complex cellular pathways, such as transcription, cell junction and transcription factor activity. KEGG pathway analysis showed that Wnt signaling pathway might be involved in regulating these 10 candidate miRNAs. XRN1 (degree = 23) and EP300 (degree = 20) had highest degree and interactions in the PPI network. Additionally, we found that HOXA11-AS was upregulated in lung adenocarcinoma and squamous cell carcinoma tissues based on TCGA database. The ROC curve revealed that the area under curve (AUC) of HOXA11-AS was 0.727 (95% CI 0.663~0.790) for lung adenocarcinoma and 0.933 (95% CI 0.906~0.960) for squamous cell carcinoma patients. Conclusions: Our results provide significant information on miRNAs related to HOXA11-AS in NSCLC and we hypothesize that HOXA11-AS might play a key role in NSCLC by regulating the expression of miRNAs through Wnt signaling pathway, which would be valuable for further investigation into the possible molecular mechanisms in NSCLC.

Overexpression of Lncrna HOXA11-AS Promotes Cell Epithelial–mesenchymal Transition by Repressing Mir-200B in Non-Small Cell Lung Cancer

LncRNA HOXA-AS2 Regulates Microrna-216A-5p to Promote Malignant Progression of Non-Small Cell Lung Cancer.

The long non-coding RNA HOXA11-AS promotes epithelial mesenchymal transition by sponging miR-149-3p in Colorectal Cancer

LncRNA CCDC144NL-AS1 Serves As a Prognosis Biomarker for Non-small Cell Lung Cancer and Promotes Cellular Function by Targeting Mir-490-3p

Prospective target gene network of key miRNAs influenced by long non-coding RNA HOXA 11-AS in NSCLC cells

Retraction Note: Upregulation of Long Noncoding RNA ZEB1-AS1 Promotes Tumor Metastasis and Predicts Poor Prognosis in Hepatocellular Carcinoma

HOXA11-AS Promotes the Migration and Invasion of Hepatocellular Carcinoma Cells by Inhibiting Mir-124 Expression by Binding to EZH2.

Clinical Significance and Effect of Lncrna HOXA11-AS in NSCLC: A Study Based on Bioinformatics, in Vitro and in Vivo Verification

Lncrna HOXA11-AS Promotes Proliferation and Migration Via Sponging Mir-155 in Hypopharyngeal Squamous Cell Carcinoma

LncRNA UCC Promotes Epithelial–mesenchymal Transition Via the Mir-143-3p/sox5 Axis in Non-Small-cell Lung Cancer

Long Noncoding RNA ZEB1-AS1 Predicts an Unfavorable Prognosis of Non-Small Lung Cancer and Regulates Epithelial to Mesenchymal Transition Through Reducing ZEB1 Expression.

Long Non-Coding Rna Hoxa-As2 Promotes Proliferation and Invasion of Breast Cancer by Acting As A Mir-520c-3p Sponge

The noncoding RNA HOXD-AS1 is a critical regulator of the metastasis and apoptosis phenotype in human hepatocellular carcinoma

Over-expressed Long Noncoding RNA HOXA11-AS Promotes Cell Cycle Progression and Metastasis in Gastric Cancer

Lncrna Hoxa11-As Promotes Proliferation And Invasion Of Gastric Cancer By Scaffolding The Chromatin Modification Factors Prc2, Lsd1, And Dnmt1

LncRNA DDX11 Antisense RNA 1 Promotes EMT Process of Esophageal Squamous Cell Carcinoma by Sponging Mir-30D-5p to Regulate SNAI1/ZEB2 Expression and Wnt/β-catenin Pathway

Silencing of Long Noncoding RNA HOXD-AS1 Inhibits Proliferation, Cell Cycle Progression, Migration and Invasion of Hepatocellular Carcinoma Cells Through MEK/ERK Pathway.

A Novel Lncrna HOXC-AS3 Acts As a Mir-3922-5p Sponge to Promote Breast Cancer Metastasis

HOXC-AS2 mediates the proliferation, apoptosis, and migration of non-small cell lung cancer by combining with HOXC13 gene

LncRNA HOXA‐AS2 promotes the progression of epithelial ovarian cancer via the regulation of miR‐372

Long noncoding RNA DNAH17-AS1 promotes tumorigenesis and metastasis of non-small cell lung cancer via regulating miR-877–5p/CCNA2 pathway